Ajanta Pharma Limited — Updates, 23-12-2025: Press Release
23-12-2025 | 05:10 pm
23-12-2025 | 05:10 pm
Ajanta Pharma partnered with Biocon for exclusive marketing of Semaglutide, a diabetes drug, in 26 countries (Africa, Middle East, Central Asia). This expands Ajanta's product portfolio and strengthens its global market presence, aiming for commercialization post-patent expiry.
No comments yet. Be the first to comment!
